Abstract
We present early estimates of influenza vaccine effectiveness (VE) in the population targeted for vaccination, during 25 December 2011 to 19 February 2012. The adjusted VE was 55% (95% CI: 3 to 79) against any type of influenza virus and 54% (95% CI: 1 to 79) against influenza A(H3N2) virus. This suggests a moderate protective effect of the vaccine in the targeted population in a late influenza epidemic with limited match between vaccine and circulating strains.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Adult
-
Aged
-
Aged, 80 and over
-
Case-Control Studies
-
Child
-
Child, Preschool
-
Female
-
Humans
-
Infant
-
Infant, Newborn
-
Influenza A Virus, H3N2 Subtype / genetics
-
Influenza A Virus, H3N2 Subtype / immunology*
-
Influenza A Virus, H3N2 Subtype / isolation & purification
-
Influenza Vaccines / administration & dosage*
-
Influenza, Human / epidemiology*
-
Influenza, Human / prevention & control*
-
Influenza, Human / virology
-
Logistic Models
-
Male
-
Middle Aged
-
Sentinel Surveillance
-
Spain / epidemiology
-
Vaccination
-
Young Adult